The study investigators plan to evaluate residual shunting in the patients who had repairs, Dr. Dawson said. He also proposed that a longer follow-up may show greater benefit from the implants.
Philadelphia Bureau Chief Mitchel L. Zoler contributed to this report.
'Using more conventional migraine trial end points, significant differences were found.' DR. DOWSON